We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+1%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$65.2B
AUM Growth
+$6.51B
(+11%)
Cap. Flow
+$6.71B
Cap. Flow
% of AUM
10.29%
Top 10 Holdings %
Top 10 Hldgs %
15.4%
Holding
2,716
New
313
Increased
1,389
Reduced
876
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$213M |
| 2 |
Cigna
CI
|
+$207M |
| 3 |
Comcast
CMCSA
|
+$164M |
| 4 |
Zoom
ZM
|
+$155M |
| 5 |
Johnson & Johnson
JNJ
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$237M |
| 2 |
TSMC
TSM
|
+$214M |
| 3 |
NVIDIA
NVDA
|
+$138M |
| 4 |
Adobe
ADBE
|
+$133M |
| 5 |
Pultegroup
PHM
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.59% |
| 2 | Financials | 13.87% |
| 3 | Industrials | 12.52% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Healthcare | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
ENI
E
$80.1B
| $533K | ﹤0.01% |
17,303
+676
| +4% | +$21.4K |
|
2027
iShares Select Dividend ETF
DVY
$23.7B
| $529K | ﹤0.01% |
4,376
| – | – |
|
2028
Construction Partners
ROAD
$6.77B
| $529K | ﹤0.01% |
9,574
+1,912
| +25% | +$106K |
|
2029
Magnolia Oil & Gas
MGY
$6.2B
| $528K | ﹤0.01% |
20,832
+4,276
| +26% | +$109K |
|
2030
Vanguard Information Technology ETF
VGT
$147B
| $527K | ﹤0.01% |
7,312
+2,240
| +44% | +$149K |
|
2031
MarineMax
HZO
$1.15B
| $524K | ﹤0.01% |
16,202
+4,905
| +43% | +$144K |
|
2032
Privia Health
PRVA
$2.83B
| $523K | ﹤0.01% |
30,081
-1,729
| -5% | -$30.6K |
|
2033
Macerich
MAC
$6.94B
| $523K | ﹤0.01% |
34,340
-35,504
| -51% | -$543K |
|
2034
Daily Journal
DJCO
$763M
| $519K | ﹤0.01% |
+1,316
| New | +$484K |
|
|
SHOE
2035
Shoe Station Group
SHOE
$425M
| $519K | ﹤0.01% |
14,066
-5,214
| -27% | -$185K |
|
2036
Piper Sandler
PIPR
$5.39B
| $519K | ﹤0.01% |
9,016
+888
| +11% | +$45.5K |
|
2037
Rio Tinto
RIO
$164B
| $518K | ﹤0.01% |
+7,852
| New | +$534K |
|
2038
Silicon Laboratories
SLAB
$7.2B
| $517K | ﹤0.01% |
4,676
-704
| -13% | -$86.9K |
|
2039
Usana Health Sciences
USNA
$258M
| $517K | ﹤0.01% |
11,428
-3,293
| -22% | -$151K |
|
|
RVNC
2040
DELISTED
Revance Therapeutics, Inc.
RVNC
| $517K | ﹤0.01% |
201,080
+170,960
| +568% | +$584K |
|
2041
Vanguard Tax-Exempt Bond Index Fund
VTEB
$46B
| $516K | ﹤0.01% |
+10,296
| New | +$515K |
|
2042
Symbotic
SYM
$5.37B
| $514K | ﹤0.01% |
+14,612
| New | +$591K |
|
2043
Amplitude
AMPL
$1.57B
| $513K | ﹤0.01% |
57,678
-31,653
| -35% | -$297K |
|
2044
First Financial Bankshares
FFIN
$5B
| $511K | ﹤0.01% |
17,468
+2,379
| +16% | +$71.2K |
|
2045
Myriad Genetics
MYGN
$307M
| $511K | ﹤0.01% |
20,910
+3,116
| +18% | +$68.4K |
|
2046
Esquire Financial Holdings
ESQ
$1.15B
| $511K | ﹤0.01% |
10,734
-69
| -0.6% | -$3.24K |
|
2047
ZipRecruiter
ZIP
$407M
| $509K | ﹤0.01% |
55,979
+22,659
| +68% | +$229K |
|
|
ORAN
2048
DELISTED
Orange
ORAN
| $509K | ﹤0.01% |
50,904
+34,812
| +216% | +$387K |
|
2049
UroGen Pharma
URGN
$2.3B
| $508K | ﹤0.01% |
30,290
-11,972
| -28% | -$170K |
|
2050
Vanguard Morningstar Value ETF
VTV
$192B
| $508K | ﹤0.01% |
3,167
+1,566
| +98% | +$250K |
|
Similar funds
VGA
AQR Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, AQR Capital Management held 2,716 positions worth $65.2B, up 11% from $58.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management deployed $6.71B of net new capital in Q2 2024, opening 313 new positions and adding to 1,389 existing holdings. Its largest new stake was Solventum: 1,217,998 shares worth $62.6M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Humana, an estimated $237M trimmed.
- AQR Capital Management's largest Q2 2024 buy was Solventum: 1,217,998 shares worth $62.6M.
- AQR Capital Management added most to ExxonMobil in Q2 2024, an estimated $213M increase.
- AQR Capital Management's biggest Q2 2024 reduction was Humana, cutting an estimated $237M.
- AQR Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $27.7M.
- AQR Capital Management's ten largest holdings make up 15% of its $65.2B portfolio in Q2 2024.
- AQR Capital Management opened 313 new positions and closed 123 in Q2 2024.
- AQR Capital Management's portfolio value rose 11% quarter-over-quarter to $65.2B.
Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.